Abstract
New paradigms suggest that many aspects of cellular function are controlled by rapid, stochastic, combinatorial processes. The implications of these new paradigms for proteomics are considered in relation to the information content of top-down and bottom-up proteomics approaches. Functional evidence and Current Proteomics experiments suggest that phenotypic variation of individual proteins is a major form of control for the combinatorial processes and that in many cases top-down proteomics approaches will be essential for proteomics investigations of cellular function. It is suggested that the new paradigms and the nature of the general cellular processes that affect protein phenotypes should be taken into account in the development of proteomics methodology. More generally, the coupling of stochastic, combinatorial processes to energy-dependent processes that change protein phenotypes may represent one of the basic principles of cellular function.
Keywords: proteomics, mass spectrometry, hypoxia, nuclear receptors, endothelin, phosphorylation
Current Proteomics
Title: New Paradigms in Cellular Function and the Need for Top-Down Proteomics Analysis
Volume: 1 Issue: 1
Author(s): Corinne Stannard, Larry R. Brown and Jasminka Godovac-Zimmermann
Affiliation:
Keywords: proteomics, mass spectrometry, hypoxia, nuclear receptors, endothelin, phosphorylation
Abstract: New paradigms suggest that many aspects of cellular function are controlled by rapid, stochastic, combinatorial processes. The implications of these new paradigms for proteomics are considered in relation to the information content of top-down and bottom-up proteomics approaches. Functional evidence and Current Proteomics experiments suggest that phenotypic variation of individual proteins is a major form of control for the combinatorial processes and that in many cases top-down proteomics approaches will be essential for proteomics investigations of cellular function. It is suggested that the new paradigms and the nature of the general cellular processes that affect protein phenotypes should be taken into account in the development of proteomics methodology. More generally, the coupling of stochastic, combinatorial processes to energy-dependent processes that change protein phenotypes may represent one of the basic principles of cellular function.
Export Options
About this article
Cite this article as:
Stannard Corinne, Brown R. Larry and Godovac-Zimmermann Jasminka, New Paradigms in Cellular Function and the Need for Top-Down Proteomics Analysis, Current Proteomics 2004; 1 (1) . https://dx.doi.org/10.2174/1570164043488243
DOI https://dx.doi.org/10.2174/1570164043488243 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Staurosporine Analogues from Microbial and Synthetic Sources and Their Biological Activities
Current Medicinal Chemistry Editorial [Hot Topic: The Chemistry and Biology of Small Molecules Acting on Nucleic Acids (Guest Editors: P.B. Arimondo, T. Garestier, J.-L. Mergny Dedicated to the Memory of Professor Claude Helene)]
Current Medicinal Chemistry - Anti-Cancer Agents Angiogenesis and Vascularization of Uterine Leiomyoma: Clinical Value of Pseudocapsule Containing Peptides and Neurotransmitters
Current Protein & Peptide Science Cardiotoxicity of Molecularly Targeted Agents
Current Cardiology Reviews Dual-target Inhibitors Based on BRD4: Novel Therapeutic Approaches for Cancer
Current Medicinal Chemistry Nanocarriers for the Simultaneous Co-Delivery of Therapeutic Genes and Anticancer Drugs
Current Pharmaceutical Biotechnology Methods for Identifying Cardiovascular Agents: A Review
Recent Patents on Cardiovascular Drug Discovery Animal Models of Carcinogenesis in Inflamed Colorectum: Potential Use in Chemoprevention Study
Current Drug Targets Next Generation Sequencing in Non-Small Cell Lung Cancer: New Avenues Toward the Personalized Medicine
Current Drug Targets Wnt/beta-Catenin Signaling and Small Molecule Inhibitors
Current Pharmaceutical Design Targeting the Lung: Preclinical and Comparative Evaluation of Anticancer Aerosols in Dogs with Naturally Occurring Cancers
Current Cancer Drug Targets Practical Aspects in the Use of Biomarkers for the Development of Cancer Vaccines
Current Cancer Therapy Reviews Applications of Polymeric Nanocapsules in Field of Drug Delivery Systems
Current Drug Discovery Technologies Developments of Combretastatin A-4 Derivatives as Anticancer Agents
Current Medicinal Chemistry Recent Advances in the Development of Catalytic Inhibitors of Human DNA Topoisomerase IIα As Novel Anticancer Agents
Current Medicinal Chemistry Designing and Formulation Optimization of Hyaluronic Acid Conjugated PLGA Nanoparticles of Tamoxifen for Tumor Targeting
Pharmaceutical Nanotechnology Inhibitors of Cyclin Dependent Kinases: Useful Targets for Cancer Treatment
Current Cancer Drug Targets Review on Triggered Liposomal Drug Delivery with a Focus on Ultrasound
Current Cancer Drug Targets Chaperoning the Cancer: The Proteostatic Functions of the Heat Shock Proteins in Cancer
Recent Patents on Anti-Cancer Drug Discovery Neuroblastoma and Stem Cell Therapy: An Updated Review
CNS & Neurological Disorders - Drug Targets